What is the significance of polychromasia and target cells on a Complete Blood Count (CBC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Polychromasia and target cells on a complete blood count (CBC) are indicative of specific blood abnormalities that require further investigation, particularly to rule out hemoglobinopathies such as thalassemia and sickle cell disease, as suggested by studies like 1. These findings can be associated with various conditions, including liver disease, post-splenectomy states, and certain metabolic disorders. Polychromasia refers to the presence of immature red blood cells (reticulocytes) that appear bluish on a blood smear due to residual RNA, suggesting increased red blood cell production in response to blood loss, hemolysis, or recovery from anemia. Target cells, also called codocytes, are red blood cells with a central concentration of hemoglobin surrounded by a pale ring and a colored outer edge, resembling a bullseye.

When these abnormalities appear together on a CBC, additional testing is recommended, including:

  • Hemoglobin electrophoresis to identify abnormal hemoglobin variants, as seen in conditions like sickle cell disease, where the ability to interpret hemoglobin electrophoresis can help clinicians distinguish between severe delayed hemolytic transfusion reaction and hyperhemolysis syndrome 2.
  • Liver function tests to assess for liver disease.
  • Possibly iron studies to evaluate for iron overload or deficiency, which can be particularly relevant in conditions like thalassemia, where iron chelation therapy is a common treatment approach 1.

The presence of both polychromasia and target cells often suggests an ongoing process affecting red blood cell production or destruction, and the underlying cause should be identified to guide appropriate treatment. Clinical correlation with the patient's symptoms, medical history, and other laboratory findings is essential for accurate diagnosis. Given the potential for these findings to indicate serious underlying conditions, prompt further evaluation and management are crucial to improve patient outcomes in terms of morbidity, mortality, and quality of life.

References

Research

Alpha- and Beta-thalassemia: Rapid Evidence Review.

American family physician, 2022

Research

Utility of hemoglobin electrophoresis to distinguish between severe delayed hemolytic transfusion reaction versus hyperhemolysis syndrome.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.